Andean Pacific Workshop on HIV & Hepatitis 2017

WHO Target 90-90-90 : Achievable for Latin America- Alejandro Afani, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

HIV in Latin America: 35 years later- Marcelo Wolff, MD, FACP, FIDSA

Slideset

HIV

Viral Hepatitis and Liver Disease

Difficult to reach populations in Latin America- Ana Paulina Celi de la Torre, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

Transmitted Drug Resistance in HIV-Infected Treatment-Naïve Patients in Chile between 2014 and 2017- Dr. Palma

Slideset

HIV

Viral Hepatitis and Liver Disease

Clinical Implications of low level viremia/ failure and resistance- Francesca Ceccherini– Silberstein, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Risk profiles for HIV transmission and HIV status in MSM versus heterosexual men populations in the South West of Colombia - Dr. Mueses-Marín

Slideset

HIV

Viral Hepatitis and Liver Disease

Moving forward to 90-90-90: Analysis of a cohort of recently-diagnosed patients in a tertiary hospital in Buenos Aires, Argentina - Dr. Barletta

Slideset

HIV

Viral Hepatitis and Liver Disease

Early diagnosis & testing- Susana Cabrera, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

High rates of retention on ART and virological suppression in a large cohort study from The Chilean AIDS Group- Dr. Beltrán

Slideset

HIV

Viral Hepatitis and Liver Disease

Strategies for hepatitis C elimination- Francesca Ceccherini– Silberstein, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

HIV- hepatitis co-infected patients- Pedro Cahn, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Implementation of DAAs in clinical management- Mark Nelson, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

HIV in Women - PTMCT - pregnancy- Isabel Cassetti, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

HIV cure and eradication- Ricardo Diaz, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

Andean Pacific Workshop on HIV & Hepatitis 2017

WHO Target 90-90-90 : Achievable for Latin America- Alejandro Afani, MD

HIV in Latin America: 35 years later- Marcelo Wolff, MD, FACP, FIDSA

Difficult to reach populations in Latin America- Ana Paulina Celi de la Torre, MD

New approaches for preventing transmission- Charles Boucher, MD, PhD

State-of-the-art lecture on PrEP- Mauro Schechter, MD, PhD

Proviral DNA as a Target for HIV-1 Resistance Analysis- Dr. Lara

Transmitted Drug Resistance in HIV-Infected Treatment-Naïve Patients in Chile between 2014 and 2017- Dr. Palma

Clinical Implications of low level viremia/ failure and resistance- Francesca Ceccherini– Silberstein, PhD

Risk profiles for HIV transmission and HIV status in MSM versus heterosexual men populations in the South West of Colombia - Dr. Mueses-Marín

Moving forward to 90-90-90: Analysis of a cohort of recently-diagnosed patients in a tertiary hospital in Buenos Aires, Argentina - Dr. Barletta

Early diagnosis & testing- Susana Cabrera, MD

High rates of retention on ART and virological suppression in a large cohort study from The Chilean AIDS Group- Dr. Beltrán

Strategies for hepatitis C elimination- Francesca Ceccherini– Silberstein, PhD

HIV- hepatitis co-infected patients- Pedro Cahn, MD, PhD

Implementation of DAAs in clinical management- Mark Nelson, MD

HIV in Women - PTMCT - pregnancy- Isabel Cassetti, MD

HIV cure and eradication- Ricardo Diaz, MD

The aging HIV infected patient - neurological issues - poly pharmacy- Ernesto Martinez Buitrago, MD